From: Prevalence of hepatopancreatic injury and clinical outcomes in patients with COVID-19 in USA
Variables | Disease severity | Mortality | Length of stay | |||||
---|---|---|---|---|---|---|---|---|
Critical vs mild/moderate | Severe vs mild/moderate | |||||||
OR | 95%CI | OR | 95%CI | OR | 95%CI | Coefficient | P value | |
Hepato-pancreatic injury | 2.710 | 2.532–2.901 | 1.398 | 1.320–1.481 | 3.389 | 3.150–3.646 | 2.004 | <0.0001 |
Age | 1.029 | 1.027–1.031 | 1.026 | 1.024–1.028 | 1.065 | 1.063–1.068 | − 0.068 | <0.0001 |
Sex (male vs female) | 1.370 | 1.284–1.461 | 1.156 | 1.092–1.224 | 1.177 | 1.110–1.248 | 0.494 | <0.0001 |
Alcohol use | 1.750 | 1.418–2.160 | 1.540 | 1.267–1.873 | 0.982 | 0.817–1.181 | 1.787 | <0.0001 |
Liver cirrhosis | 1.941 | 1.620–2.327 | 1.798 | 1.516–2.133 | 1.321 | 1.163–1.500 | 0.889 | <0.0001 |